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Abstract
Background/Aim. Therapy of the early stages of cervical car-
cinoma is surgical or radiation therapy, and for advanced stages
chemoradiotherapy. Pelvic and paraaortic lymphadenectomy in
early stages offers the most important prognostic factor for sur-
vival. To evaluate the method and possible influence on surgical
staging and therapy of the disease, we performed sentinel node
(SN) identification and excision during open radical hysterectomy
and lymphadenectomy in stage Ib-IIa cervical carcinoma. Meth-
ods. Fifty patients initially diagnosed with invasive squamous-cell
cervical cancer stage Ib-IIa were included in the study. Only blue
dye was used for sentinel node mapping. During the surgery senti-
nel nodes were identified and sent to histopathology separately
from the other lymph nodes. After lymphadenectomy, radical
hysterectomy was performed. Results. The mean age of our fifty
patients was 49.10 years (SD = 5.92), and the mean number of ex-
tracted lymph nodes per patient was 25.78 (SD = 5.58). The num-
ber of sentinel nodes identified per patient was between 0 and 5,
mean 2.60 (SD = 1.54). There were no inframesenteric paraaortic
sentinel nodes found among the patients. The dominant tumor
grades were 1 and 2, 40% and 50% respectively, and 37 out of 50
patients (74%) had tumor diameter less than 2 cm. In four patients
(8%) SN were not identified. In the rest of 46 patients the presence
of SN was bilateral (19 patients, 38%) or unilateral (27 patients,
54%). Positive SN were found in 17 patients (34%), and negative
in 29 patients (58%). Out of the whole group of patients (50), 21
of them (42%) had positive lymph nodes (LN). In the crosstab
statistics, no differences were noticed in the group without SN
found, in comparison with tumor grade and diameter. Finally, our
test showed sensitivity of 85% (SE = 8%), specificity 100%, posi-
tive predictive value of 100%, negative predictive value of 89.6%
(SE = 5.6%),  and  effectiveness  of  93%  (SE = 3.6%)  regarding
sentinel lymphadenectomy. Conclusion. This method of sentinel
lymph node identification is simple, but not reliable enough to
support further laparoscopic SN excision in order to make the final
decision about the treatment of cervical cancer.
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Apstrakt
Uvod/Cilj. Terapija za  karcinom cerviksa početne faze je hi-
rurška ili zračna, dok se za poodmakle faze primenjuje hemora-
dioterapija. Limfadenektomija pelvisa i paraovarijuma u počet-
nim fazama obezbeđuje najvažniji faktor prognoze preživljava-
nja. Cilj ove studije bio je da se odredi metoda i njen mogući uti-
caj na hirurško utvrđivanje faze i terapije primenom identifikacije
sentinelnog čvora (sentinel node – SN) i ekscizije tokom otvorene
radikalne histerektomije i limfadenektomoje karcinoma cerviksa
faze Ib – Ia. Metode. U studiju je bilo uključeno 50 bolesnica sa
početnom dijagnozom skvamoznog karcinoma cerviksa faze Ib
– Ia. Za mapiranje sentinelnog čvora bilo je primenjeno samo
plavo bojenje. Tokom hirurške intervencije vršena je identifika-
cija i slanje sentinelnih čvorova na histopatološku analizu odvo-
jeno od ostalih limfnih čvorova. Posle limfadenektomije vršena je
histerektomija. Rezultati. Prosečna starost ispitivanih bolesnica
bila je 49,10 godina (SD = 5,92), a srednji broj ekstrahovanih lim-
fnih čvorova po bolesnici bio je 25,78 (SD = 5,58). Broj identifi-
kovanih sentinelnih čvorova po bolesnici bio je 0–5, prosečno
2,60 (SD = 1,54). Kod bolesnica nisu nađeni inframezenterični
sentinelni čvorovi. Dominantni gradusi tumora bili su 1 i 2, 40% i
50%, respektivno, dok je 37 od ukupno 50 bolesnica (74%)
imalo tumor prečnika ispod 2 cm. Kod četiri (8%) bolesnice SN
nije identifikovan, ali je kod preostalih 46 bolesnica SN bio obo-
stran, (n = 19; 38%), ili jednostran, (n = 27; 54%). Pozitivni SN
nađen je kod 17 (34%) bolesnica, a negativni kod 29 (58%). Od
ukupnog broja bolesnica (n = 50) cele grupe, 21 (42%) imala je
pozitivne limfne čvorove. Uporedna statistika nije pokazala razli-
ke u grupi bez SN u pogledu gradusa i prečnika tumora. Najzad,
ispitivanje je pokazalo osetljivost 85% (SE = 8%), specifičnost
100%, pozitivnu prediktivnu vrednost 100%, negativnu predikti-
vnu vrednost 89,6% (SE = 5,6%) i efikasnost 93% (SE = 3,6%)
sentinelne limfadenektomije. Zaključak. Ova metoda identifika-
cije sentinelnog limfnog čvora spada u jednostavne, ali nedovolj-
no pouzdane za podršku dalje laparoskopske ekscizije SN da bi
se donela krajnja odluka o tretmanu karcinoma cerviksa.
Ključne reči:
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Introduction
The global incidence of almost 400 000 cases and the
annual death rate of nearly half the previous estimate
qualifies cervical cancer as one of the greatest XXI cen-
tury problems 
1. Whereas preinvasive disease makes no
problem after diagnosis, invasive cervical cancer still re-
mains an issue of debate on therapeutic approach, particu-
larly in the early stages. So far, a management plan de-
pends not only on the anatomical extent of the disease, but
also on age and general health of a patient 
2. “The staging
of cancer of the cervix is a clinical appraisal, preferably
confirmed in a patient under anesthesia; it cannot be
changed later if findings at operation or subsequent treat-
ment reveal further advancement of the disease” 
2. With
the aim to achieve utmost accuracy in determining clinical
staging, we occasionally use, apart from physical exami-
nation, radiography, colposcopy, cystoscopy, proctosig-
moidoscopy, intravenous pyelogram (IVP) and barium en-
ema. Lymphography, computerized tomography, magnetic
resonance imaging, arteriography, venography, laparos-
copy and hysteroscopy are not recommended for staging,
as they have not been standardized 
2. It is usual for early
stages to be treated by surgery or radiation therapy, and for
advanced stages to be treated by chemoradiotherapy 
2.
Pelvic and paraaortic lymphadenectomy in early stages of-
fers the most important prognostic factor for survival 
3.
Whether it should influence the decision about radical sur-
gery or radiotherapy and in which cases, remains to be
discussed 
4. One question, however, seems to be answered:
brachytherapy is much more effective with the uterus in
situ. Also, there are some authors who support the oppin-
ion on therapeutic benefit in dissection of positive, en-
larged lymph nodes, so that doses of radiotherapy can be
successful in eradication of metastatic disease 
5–7. High
morbidity in patients who undergo radical surgery fol-
lowed by radiotherapy makes many surgeons avoid sur-
gery in case of lymph node involvement in order to im-
prove life quality and retain good results 
8.
Therefore, the assessment of lymph node (LN) status
seems to be important for the decision regarding the treat-
ment plan 
9. Whether sentinel nodes (SN) represent the LN
status of the region is still questionable.
Sentinel node mapping is performed using blue dye
and/or 
99Technetium (
99Tc). After Malur 
10 and Levenback
et al. 
11, the accuracy of the combined method is between
90 and 100%, compared to 50–70% when using blue dye
and 
99Tc separately 
12–15. Recently, Marchiole et al 
16 re-
ported the false-negative rate of 12.5% which lowers a
negative predictive value down to 87.5%, as the most im-
portant issue.
The aim of this prospective study was to evaluate SN
mapping using blue dye, as the representative of the LN
status. This would potentially lead to a better judgement in
deciding whether to perform radical hysterectomy in patients
with cervical cancer at an early stage, all on the basis of
minimally invasive surgery (endoscopy) 
17–19.
Methods
The number of radical hysterectomies performed in our
clinic slightly varies, it is about 140 annually for the past five
years. This number represents a failure of prevention pro-
grams, as well as the concentration of cases in a couple of
centers in our country.
Every patient with invasive cervical cancer has to be
examined by a board of physicians, and after their consider-
ing the case, the decision on therapeutic approach is made.
That is a general rule. After that, patients are referred for
surgery stay in our clinic, and the others are sent into the re-
gional oncology centers for radio- and chemotherapy.
Our study group consisted of 50 patients, randomly se-
lected among those with invasive squamouscell cervical can-
cer, clinically staged as FIGO stage Ib-IIa and referred for
radical hysterectomy. The research lasted from March 2003
to December 2004.
For SN identification we chose only blue dye for two
reasons: firstly, the easy-performing method offers chances
to be widely accepted; secondly, and more importantly, the
use of 
99Tc as a standard procedure is still not feasible in our
clinic.
Thirty minutes prior to operation we injected 3 mL of
blue dye in each side of cervix (clock position 3 and 9) 
20.
During the course of the procedure we identified SN, excised
them and sent them to histopathology separately from the
others. After that we performed paraaortic lymphadenectomy
up to the inferior mesenteric artery, bilateral pelvic lymph-
adenectomy, and finally, radical class III hysterectomy.
All relevant data underwent statistical analysis. We
used descriptive statistics, frequency tables, logistic regres-
sion, Student t test, crosstabs and χ
2 test.
Results
Our study lasted 22 months, and all the radical hyster-
ectomies were performed by the authors of this paper.
The mean age of our patients was 49.10 years
(SD = 5.92) in the 38–67 age group.
Twenty patients (40%) had grade I tumor, 25 (50%) had
grade II tumor, the remaining 5 patients (10%) had grade III
tumor.
A tumor smaller than 2 cm in diameter was found in 37
patients (74%). We found 11 (22%) cases with tumors be-
tween 2 and 4 cm in diameter, and 2 cases (4%) with tumors
larger than 4 cm in diameter. The correlation between nodal
metastases and the tumor size fits relevant data 
21.
The mean number of extracted lymph nodes per patient
was 25.78 (SD = 5.58), ranging from 15 to 39.
The number of SN identified per patient varied between
0 and 5, with the mean value of 2.60 (SD = 1.54).
There were no inframesenteric paraaortic SN found in
the group of patients, yet in four patients (8%) nodes of that
location were positive.
In four patients (8%) SN were not identified and in all
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In the rest 46 patients the presence of SN was bilateral
(19 patients, 38%) or unilateral (27 patients, 54%). The posi-
tive SN were found in 17 patients (34%) and negative in 29
patients (58%).
Out of the whole group of patients (n = 50), 21 of them
(42%) had positive LN.
Crosstab statistics showed no difference between “no
SN found” group and the rest of the patients, regarding tu-
mor grade and diameter.
In five cases (10%) we noticed complete staining of the
posterior leaf of the broad ligament.
Our test showed sensitivity of 85% (SE  =  7.98%),
specificity of 100% (SE = 0%), positive predictive value of
100% (SE  =  0%), negative predictive value of 89.6%
(SE = 5.6%) and effectiveness of 93% (SE = 3.6%).
Discussion
Clinical staging of cervical cancer has, so far, been
mandatory in defining the extent of the disease, and radical
hysterectomy, with pelvic and paraaortic lymphadenectomy,
is the mainstay of therapy for the early stages (Ib-IIa). Al-
though confident enough to discover parametrial infiltration,
clinical examination is not reliable in discovering the nodal
metastatic disease.
Additional diagnostic tools that we use in an attempt to
check up lymph node status are not, unfortunately, accurate
enough 
22–24. That is the reason why we often exceed limits
of an adequate therapy in terms of an overtreatment or un-
dertreatment. In our attempt to tailor the treatment to the
measure of the disease, we turn to surgical staging in order to
obtain relevant data. On the other hand, surgical staging
would be potentially beneficial only if we could individual-
ize treatment and perform it less radically in some cases
(nerve sparing surgery, preservation of fertility, better clini-
cal outcome, etc) 
22–28.
Metastases in LN are the predictors of bad prognosis in
the early stages of cervical cancer 
3. They put the patient into
the high-risk group for adjuvant oncological therapy, which
is almost inevitable. That is the reason we all want to know
about the LN status before radical surgery, if possible before
systemic lymphadenectomy, as well.
The matter of debate is the question of wheather SN
could represent LN status with acceptable probability or not.
If yes, the next question is about the method of sentinel map-
ping, which should be as simple and efficient as it could be.
Finally, the answer is yet to come if there is any real benefit
of sentinel biopsy.
The central point of our work is the evaluation of our
method of SN mapping by the use of blue dye only.
As it has previously been said, the combination of
blue dye injection and 
99Tc lymphography significantly im-
proves the accuracy of SN detection according to numerous
authors, but the data are still inconsistent 
29–31. However, it
is not applied in our clinic as a routine procedure and,
probably, neither it is in many other clinics Besides, some-
one will find lymphography not so convenient for the pa-
tient. On the other hand, injection of blue dye is a simple
and convenient procedure, short-lasting and performed
while a patient is already under general anesthesia for the
surgery 
32, 33.
We choose to inject the contrast in clock positions 3
and 9 of the cervix rather than to inject it in the tumor itself,
in order to prevent additional metastatic spread and achieve
bilateral mapping. We found the volume of 3 ml to each side
optimal regarding cervical compliance and staining potential
in several testings before starting the study 
20. We choose a
30-minute period of time because it enables at least pelvic
SN staining, during which we usually do the necessary
preparations of the operative field.
The mean age of 49 years reveals a typical group of pa-
tients 
2, 21.
We choose the most common histopathological type,
squamous-cell carcinoma, supposing that merging with other
types (ie adenocarcinoma) may potentially influence the re-
sults.
The distribution of tumor sizes and histological tumor
grades is listed in the results. The percentage of lymph node
involvement according to the tumor size fits the other rele-
vant data.
An average number of lymph nodes in pelvis is about
50 and changes during a lifetime. Our lymphadenectomy of
25–26 LN per patient seems to represent the European stan-
dard 
34.
The mean number of 2.6 SN per patient (range from 0–
5) would be close to our intentions 
35. Unfortunately, in four
patients (8%) we could not find SN at all. In the subsequent
statistics they were treated as missing, but that fact affected
sensitivity (drop to 85%) and effectiveness (drop to 93%).
Furthermore, we could not find any inframesenteric paraaor-
tic SN in the whole group of patients. It is worth repeating
that we have performed inframesenteric paraaortic lymph-
adenectomy for Benedetti-Panici 
36 reasons, and because this
region is laparoscopically easily accessible. However, our
finding is not in correlation with other data showing about
9% paraaortic SN found in stage Ib1, marking this location
as the first place of metastatic spread in about 9% in stage
Ib1 
10, 11, 37–39. Perhaps, we would have found some SN per-
forming complete paraaortic lymphadenectomy, but then, the
question of sentinel mapping would arise again. Also, the
time distance from dye injection to SN excision (30–35 min)
could have been rather short for LN staining. Still, we have
8% inframesenteric paraaortic LN positive in stages Ib-IIa,
all of them with positive pelvic SN, therefore, not influenc-
ing the statistics.
The percentage of lymph node involvement according
to the stage of disease (42%) in our material is significantly
higher than in other reports (about 30) 
21. Reevaluation of
histopathological materials showed no understaging.
In the group of patients (n = 4; 8%) without SN found,
there was no difference regarding the tumor grade and di-
ameter when compared to the rest of the patients (n = 46;
92%).
In five cases, besides SN being found, a complete
staining of the posterior leaves of the broad ligaments oc-
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results showing parametrial extension in 7% of Ib stage pa-
tients and 34% of IIb stage patients 
40.
Our method for SN mapping is simple, fast and com-
fortable both for the patient and the doctor, yet having com-
parable values 
30. The shortcomings are less efficiency and
lower negative predictive value than in the more sophisti-
cated, combined 
99Tc + blue dye lymphography 
41. Having in
mind that even the combined method has not yet convinced
gynecologic oncologists in its supperiority and neccessity,
we think that there is some space for this procedure in se-
lected cases. Perhaps, a part of the problem regarding the
extended field radiation could be solved by performing exci-
sion of all inframesenteric paraaortic lymph nodes as the first
step. After that, pelvic SN mapping could be usefull in some
cases.
Conclusion
This method of sentinel lymph node identification is
simple, but not reliable enough to support further laparo-
scopic SN excision in order to make the final decision about
the treatment of cervical cancer.
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